An earlier diagnosis to avoid kidney transplants

November 29, 2011 By Isabelle Quinkal, SOLEIL Synchrotron
Figure legend: Optical microscopy image (a) and IR micro-spectroscopy maps (b and c) of the same portion of a kidney biopsy. The colors range from blue to red depending on the increasing concentration of the compound measured. b) Crystalline compound measured is carbapatite c) Crystalline compound measured is sodium hydrogen urate monohydrate Right: an example of spectra from which the maps were obtained.

An analytical technique using high brilliance infrared light produced by the SOLEIL synchrotron has been developed by teams from the CNRS, Paris Sud University, Tenon Hospital in Paris, and the Stoke-on-Trent Cancer Centre (GB) to study the calcification present in the kidneys of patients with renal failure. The results show that it is now possible to identify different types of calcification, some of which are specific to diseases that can be treated. If this information is obtained early, the patients concerned can be treated on time and avoid kidney loss and an eventual kidney transplant.

Chronic renal failure, the end-stage of which is lethal, is increasing dramatically in . While the main cause is , renal crystal deposit diseases can also lead to end-stage . For the latter, though most forms can be treated medically if diagnosed in time, the only alternative is a kidney transplant. Renal crystal deposit diseases are rare and as a result often misdiagnosed. When a patient suffers from such a disease, without knowing it, and then undergoes a , the new kidney will in turn be affected. Calcifications form and clog the kidney tubules, gradually preventing their function completely, which must then be taken over by , a very restrictive and major procedure, leading to renal transplantation, if this is possible.

Yet renal crystal deposit diseases are curable by appropriate drug treatments. It is therefore easy to understand the importance of being able to diagnose these in patients, to avoid the necessity of carrying out an operation as serious as a transplant - not to mention the fact that is rare.

A unique analysis technique

Such a diagnosis can be carried out on calcifications present in the kidney. Several kinds of calcifications exist: some signal specific crystal deposit diseases, whereas others are the consequences of poor and are not specific to the diseases under investigation. It is therefore necessary to be able to distinguish between them.

Characterization techniques, based on the differential staining of these calcifications, are already used in hospitals, but these do not differentiate precisely between the kinds of calcifications. In contrast, infrared micro-spectroscopy using synchrotron radiation (SR μFTIR) lifts the uncertainty in a few minutes, and this from samples that may be less than ten microns in size, which is not the case with the conventional FTIR spectroscopy that is available in some laboratories but is not sensitive enough at the scale of the size of the calcifications. Information is obtained as a chemical map of the sample: each pixel of a few square microns on the map provides the precise chemical composition of the .

Groups from CNRS, Paris Sud University, Tenon Hospital in Paris, and the Stoke-on-Trent Cancer Centre (GB) analyzed more than twenty kidney biopsies on the SMIS beamline at SOLEIL synchrotron from patients suffering from various kidney diseases. Due to the intensity of infrared radiation and the microscopic size of the light spot analyzing the samples, the researchers managed to identify several types of crystals, the composition of which was observed in some cases for the first time. Another discovery: a single biopsy can contain two or three different crystalline phases. This is the first scientific evidence of the diversity and heterogeneity of calcifications found in tissues.

These results show that the SRμFTIR technique is an exceptional and unique tool for analyzing calcifications associated with kidney alteration. Hopefully they will bring great improvements in the early diagnosis and treatment of some kidney diseases, so far treated by often repeat kidney transplants, because of the destruction of one or more successive grafts by the unidentified crystal deposits.

Explore further: Continued treatment for lupus may boost survival of those patients with end-stage kidney disease

More information: Shedding light on the chemical diversity of ectopic calcifications in kidney tissues: Diagnostic and research aspects,A. Dessombz et al., PLoS ONE (2011).

Related Stories

Continued treatment for lupus may boost survival of those patients with end-stage kidney disease

September 20, 2011
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney ...

Aboriginal children less likely to receive kidney transplants

May 24, 2011
Aboriginal children with kidney failure were less likely to receive a kidney transplant compared to white children, found an article in CMAJ (Canadian Medical Association Journal).

Recommended for you

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.